{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T06:05:02Z","timestamp":1789625102600,"version":"build-2803163510"},"reference-count":43,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"34","license":[{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Clinical Key Specialty Construction Project, Tianjin Key Medical Discipline Project","award":["TJYXZDXK-3-032C"],"award-info":[{"award-number":["TJYXZDXK-3-032C"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,8,21]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      Polymyositis (PM), an autoimmune muscle disorder, often leads to interstitial lung disease (ILD), including idiopathic pulmonary fibrosis (IPF). However, causality and mechanisms are unclear. This study aimed to investigate the causal effect of PM on IPF risk, identify potential mediating biomarkers through multi-omics analysis, and explore candidate therapeutic drugs. Two-sample Mendelian randomization (MR) was conducted using publicly available genome-wide association study (GWAS) summary statistics (PM: 244 cases\/4,28,965 controls; IPF: 6257 cases\/9,47,616 controls). Reverse-causality was evaluated via bidirectional MR. We acknowledge the potential for sample overlap between exposure and outcome datasets when using public GWAS data. To mitigate related biases, we employed robust MR methods, including inverse-variance weighted (IVW) with random effects, MR-Egger, and MR-PRESSO, that are less sensitive to such overlap. Genetic variants with significant missing data or poor imputation quality were excluded as per the quality control standards of the original GWAS. This specific analysis was not preregistered and should be considered exploratory. The analysis proceeded in two sequential phases to identify shared causal mediators: First, MR analyses were conducted with 91 inflammatory proteins, 1400 plasma metabolites, 4907 circulating proteins, and 731 immune cell traits as exposures and IPF as the outcome to identify significant causal biomarkers for IPF. Second, MR analyses were conducted with PM as the exposure and the biomarkers significantly associated with IPF as outcomes to identify those also influenced by PM with consistent effect directions. Identified key proteins underwent functional enrichment analysis. Molecular docking was used to validate interactions between significant mediators and potential drugs. PM significantly increased IPF risk (odds ratio [OR]: 1.06, 95% confidence interval [CI]: 1.02\u20131.09,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.01), with no significant reverse causal evidence. Five circulating proteins (AMH, CHCHD10, CRABP2, HERC5, HSPA5) and 5 metabolites mediated this association, enriched in endoplasmic reticulum stress and transforming growth factor (TGF-\u03b2) signaling. Three drugs (butein, gambogic acid, tauroursodeoxycholic acid) showed strong binding affinity (\u0394G\u2005&lt;\u2005\u22127.0 kcal\/mol). Genetic evidence supports PM causally increasing IPF risk. Multi-omics revealed key mediating biomarkers and underlying biological pathways, while drug target prioritization identified 3 compounds with therapeutic potential. This informs prevention strategies.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000050168","type":"journal-article","created":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T17:01:32Z","timestamp":1787331692000},"page":"e50168","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Causal link between polymyositis and idiopathic pulmonary fibrosis in individuals of European ancestry"],"prefix":"10.1097","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1385-6206","authenticated-orcid":false,"given":"Miaomiao","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, Tianjin Chest Hospital, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Tong","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, West China (Airport) Hospital of Sichuan University, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiying","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Emergency and Critical Care, Tianjin University Chest Hospital, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yazheng","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, Tianjin Chest Hospital, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, West China (Airport) Hospital of Sichuan University, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-5895-8633","authenticated-orcid":false,"given":"Bin","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, Chest Hospital, Tianjin University, Tianjin, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260917","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s00292-019-00747-x","article-title":"Idiopathic pulmonary fibrosis-epidemiology, causes, and clinical course.","volume":"41","author":"Sch\u00e4fer","year":"2020","journal-title":"Pathologe"},{"key":"R2-20260917","doi-asserted-by":"crossref","first-page":"1340310","DOI":"10.3389\/fmed.2024.1340310","article-title":"Myositis-associated antibodies predict the severity of lung involvement in adult patients with inflammatory myositis - a cohort study of 70 adult patients with myositis in a single center.","volume":"11","author":"Marklund","year":"2024","journal-title":"Front Med (Lausanne)"},{"key":"R3-20260917","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1093\/jalm\/jfab108","article-title":"Myositis antibodies and interstitial lung disease.","volume":"7","author":"Basuita","year":"2022","journal-title":"J Appl Lab Med"},{"key":"R4-20260917","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3390\/medicina55040083","article-title":"Epithelial\u2212mesenchymal transition in the pathogenesis of idiopathic pulmonary fibrosis.","volume":"55","author":"Salton","year":"2019","journal-title":"Medicina (Kaunas)"},{"key":"R5-20260917","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s12931-018-0838-4","article-title":"A role for telomere length and chromosomal damage in idiopathic pulmonary fibrosis.","volume":"19","author":"McDonough","year":"2018","journal-title":"Respir Res"},{"key":"R6-20260917","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.matbio.2018.03.021","article-title":"Idiopathic pulmonary fibrosis: epithelial-mesenchymal interactions and emerging therapeutic targets.","volume":"71-72","author":"Hewlett","year":"2018","journal-title":"Matrix Biol"},{"key":"R7-20260917","doi-asserted-by":"crossref","first-page":"100192","DOI":"10.1016\/j.xgen.2022.100192","article-title":"Global biobank meta-analysis initiative: powering genetic discovery across human disease.","volume":"2","author":"Zhou","year":"2022","journal-title":"Cell Genom"},{"key":"R8-20260917","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1038\/s41590-023-01588-w","article-title":"Genetics of circulating inflammatory proteins identifies drivers of immune-mediated disease risk and therapeutic targets.","volume":"24","author":"Zhao","year":"2023","journal-title":"Nat Immunol"},{"key":"R9-20260917","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s41588-022-01270-1","article-title":"Genomic atlas of the plasma metabolome prioritizes metabolites implicated in human diseases.","volume":"55","author":"Chen","year":"2023","journal-title":"Nat Genet"},{"key":"R10-20260917","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1038\/s41588-021-00978-w","article-title":"Large-scale integration of the plasma proteome with genetics and disease.","volume":"53","author":"Ferkingstad","year":"2021","journal-title":"Nat Genet"},{"key":"R11-20260917","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1038\/s41588-020-0684-4","article-title":"Complex genetic signatures in immune cells underlie autoimmunity and inform therapy.","volume":"52","author":"Orr\u00f9","year":"2020","journal-title":"Nat Genet"},{"key":"R12-20260917","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/ije\/dyr036","article-title":"Avoiding bias from weak instruments in Mendelian randomization studies.","volume":"40","author":"Burgess","year":"2011","journal-title":"Int J Epidemiol"},{"key":"R13-20260917","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1093\/ije\/dyq151","article-title":"Power and instrument strength requirements for Mendelian randomization studies using multiple genetic variants.","volume":"40","author":"Pierce","year":"2011","journal-title":"Int J Epidemiol"},{"key":"R14-20260917","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.mayocp.2013.11.018","article-title":"Frequency and implication of autoimmune serologies in idiopathic pulmonary fibrosis.","volume":"89","author":"Moua","year":"2014","journal-title":"Mayo Clin Proc"},{"key":"R15-20260917","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s10067-009-1110-6","article-title":"Interstitial lung disease in polymyositis and dermatomyositis.","volume":"28","author":"Chen","year":"2009","journal-title":"Clin Rheumatol"},{"key":"R16-20260917","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1002\/art.30513","article-title":"Short-term and long-term outcomes of interstitial lung disease in polymyositis and dermatomyositis: a series of 107 patients.","volume":"63","author":"Marie","year":"2011","journal-title":"Arthritis Rheum"},{"key":"R17-20260917","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1186\/s12890-025-03836-1","article-title":"Incidence and prevalence of idiopathic pulmonary fibrosis: a systematic literature review and meta-analysis.","volume":"25","author":"Golchin","year":"2025","journal-title":"BMC Pulm Med"},{"key":"R19-20260917","doi-asserted-by":"crossref","first-page":"C689","DOI":"10.1152\/ajpcell.00586.2020","article-title":"Cellular metabolomics of pulmonary fibrosis, from amino acids to lipids.","volume":"320","author":"Roque","year":"2021","journal-title":"Am J Physiol Cell Physiol"},{"key":"R20-20260917","doi-asserted-by":"crossref","first-page":"21912","DOI":"10.1038\/s41598-020-78951-6","article-title":"Serum metabolites as biomarkers in systemic sclerosis-associated interstitial lung disease.","volume":"10","author":"Meier","year":"2020","journal-title":"Sci Rep"},{"key":"R21-20260917","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/resp.13465","article-title":"Molecular breath analysis supports altered amino acid metabolism in idiopathic pulmonary fibrosis.","volume":"24","author":"Gaugg","year":"2019","journal-title":"Respirology"},{"key":"R22-20260917","doi-asserted-by":"crossref","first-page":"661129","DOI":"10.3389\/fphar.2021.661129","article-title":"Tianlongkechuanling inhibits pulmonary fibrosis through down-regulation of arginase-ornithine pathway.","volume":"12","author":"Zhang","year":"2021","journal-title":"Front Pharmacol"},{"key":"R23-20260917","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1021\/acs.jproteome.1c00977","article-title":"1H qNMR-based metabolomics discrimination of covid-19 severity.","volume":"21","author":"Correia","year":"2022","journal-title":"J Proteome Res"},{"key":"R24-20260917","doi-asserted-by":"crossref","first-page":"e99096","DOI":"10.1172\/jci.insight.99096","article-title":"Untargeted metabolomics identifies trimethyllysine, a TMAO-producing nutrient precursor, as a predictor of incident cardiovascular disease risk.","volume":"3","author":"Li","year":"2018","journal-title":"JCI Insight"},{"key":"R25-20260917","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1124\/jpet.107.131565","article-title":"Ceramide: a key signaling molecule in a Guinea pig model of allergic asthmatic response and airway inflammation.","volume":"324","author":"Masini","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"R26-20260917","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/nm1748","article-title":"Ceramide accumulation mediates inflammation, cell death and infection susceptibility in cystic fibrosis.","volume":"14","author":"Teichgr\u00e4ber","year":"2008","journal-title":"Nat Med"},{"key":"R27-20260917","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1177\/1753465811406772","article-title":"The role of sphingolipids in respiratory disease.","volume":"5","author":"Yang","year":"2011","journal-title":"Ther Adv Respir Dis"},{"key":"R28-20260917","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s12890-017-0513-4","article-title":"Identification of the lipid biomarkers from plasma in idiopathic pulmonary fibrosis by Lipidomics.","volume":"17","author":"Yan","year":"2017","journal-title":"BMC Pulm Med"},{"key":"R29-20260917","doi-asserted-by":"crossref","first-page":"4257","DOI":"10.3390\/ijms21124257","article-title":"Lipid mediators regulate pulmonary fibrosis: potential mechanisms and signaling pathways.","volume":"21","author":"Suryadevara","year":"2020","journal-title":"Int J Mol Sci"},{"key":"R30-20260917","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1471-2466-14-5","article-title":"Docosatetraenoyl LPA is elevated in exhaled breath condensate in idiopathic pulmonary fibrosis.","volume":"14","author":"Montesi","year":"2014","journal-title":"BMC Pulm Med"},{"key":"R31-20260917","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1164\/rccm.202309-1692OC","article-title":"Machine learning of plasma proteomics classifies diagnosis of interstitial lung disease.","volume":"210","author":"Huang","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"key":"R32-20260917","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1021\/acs.jproteome.2c00532","article-title":"Proteomics analysis of plasma-derived exosomes unveils the aberrant complement and coagulation cascades in dermatomyositis\/polymyositis.","volume":"22","author":"Meng","year":"2023","journal-title":"J Proteome Res"},{"key":"R33-20260917","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/nrendo.2011.224","article-title":"Anti-M\u00fcllerian hormone: an ovarian reserve marker in primary ovarian insufficiency.","volume":"8","author":"Visser","year":"2012","journal-title":"Nat Rev Endocrinol"},{"key":"R34-20260917","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/ana.26959","article-title":"DNA methylation in the anti-mullerian hormone gene and the risk of disease activity in multiple sclerosis.","volume":"96","author":"Giordano","year":"2024","journal-title":"Ann Neurol"},{"key":"R35-20260917","doi-asserted-by":"crossref","first-page":"5447","DOI":"10.3390\/ijms23105447","article-title":"Consensus gene co-expression network analysis identifies novel genes associated with severity of fibrotic lung disease.","volume":"23","author":"Ghandikota","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R36-20260917","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1007\/s00018-016-2139-8","article-title":"Functional and pathological relevance of HERC family proteins: a decade later.","volume":"73","author":"S\u00e1nchez-Tena","year":"2016","journal-title":"Cell Mol Life Sci"},{"key":"R37-20260917","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1002\/ijc.29298","article-title":"Identification of HERC5 and its potential role in NSCLC progression.","volume":"136","author":"Wrage","year":"2015","journal-title":"Int J Cancer"},{"key":"R38-20260917","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1186\/s12967-015-0743-2","article-title":"HERC5 is a prognostic biomarker for post-liver transplant recurrent human hepatocellular carcinoma.","volume":"13","author":"Xue","year":"2015","journal-title":"J Transl Med"},{"key":"R39-20260917","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1093\/carcin\/bgab053","article-title":"Downregulation of HERC5 E3 ligase attenuates the ubiquitination of CtBP1 to inhibit apoptosis in colorectal cancer cells.","volume":"42","author":"Zhu","year":"2021","journal-title":"Carcinogenesis"},{"key":"R40-20260917","doi-asserted-by":"crossref","first-page":"908","DOI":"10.3390\/ijms20040908","article-title":"Twin CHCH proteins, CHCHD2, and CHCHD10: key molecules of Parkinson\u2019s disease, amyotrophic lateral sclerosis, and frontotemporal dementia.","volume":"20","author":"Imai","year":"2019","journal-title":"Int J Mol Sci"},{"key":"R41-20260917","doi-asserted-by":"crossref","first-page":"1166680","DOI":"10.3389\/fimmu.2023.1166680","article-title":"New progresses on cell surface protein HSPA5\/BiP\/GRP78 in cancers and COVID-19.","volume":"14","author":"Li","year":"2023","journal-title":"Front Immunol"},{"key":"R42-20260917","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.matbio.2018.03.015","article-title":"Endoplasmic reticulum stress in pulmonary fibrosis.","volume":"68-69","author":"Burman","year":"2018","journal-title":"Matrix Biol"},{"key":"R43-20260917","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.kint.2024.04.015","article-title":"Tauroursodeoxycholic acid ameliorates renal injury induced by COL4A3 mutation.","volume":"106","author":"Yu","year":"2024","journal-title":"Kidney Int"},{"key":"R44-20260917","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s40035-022-00307-z","article-title":"Tauroursodeoxycholic acid: a potential therapeutic tool in neurodegenerative diseases.","volume":"11","author":"Khalaf","year":"2022","journal-title":"Transl Neurodegener"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050168","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T06:00:43Z","timestamp":1789624843000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050168"}},"subtitle":["A Mendelian randomization and multi-omics study identifying mediators and drug targets"],"short-title":[],"issued":{"date-parts":[[2026,8,21]]},"references-count":43,"journal-issue":{"issue":"34","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000050168","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,21]]},"assertion":[{"value":"2025-08-14","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-28","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}